Gli indicatori clinici e strumentali nello scompenso cardiaco cronico: Sappiamo come usarli?

Giornale Italiano di Cardiologia

Volumn 27, Issue 2, 1997, Pages 173-180

  Opasich, Cristina ^a   Cobelli, Franco ^a   Tavazzi, Luigi ^a  

^a IRCCS   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

CONGESTIVE HEART FAILURE; HUMAN; REVIEW;

BIOLOGICAL MARKERS; HEART FAILURE, CONGESTIVE; HUMANS;

EID: 1842791818     PISSN: 00465968     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (72)

1. GLASS M: The patient-physician relationship. JAMA 1996; 275: 147-148.
2. PARMLEY WW: Clinical decision making: what is the evidence? J Am Coll Cardiol 1996; 27: 736.
3. YUSUF S, GARG R: Design, results, and interpretation of randomized, controlled trials in congestive heart failure and left ventricular dysfunction. Circulation 1993; 87 (Suppl VII): 115-121.
4. BRAITMAN LE, DAVIDOFF F: Predicting clinical states in individual patients. Ann Intern Med 1996; 125: 406-412.
5. THE CARDIAC INSUFFICIENCY BISOPROLOL STUDY (CIBIS): A randomized trial of β-blockade in heart failure. Circulation 1994; 90: 1765-1773.
6. DOVAL H, NUL D, GRANCELLI H, ET AL: Randomised trial of low-dose amiodarone in severe congestive heart failure. Lancet 1994; 344: 493-498.
7. SINGH S, FLETCHER R, FISHER S, ET AL: Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. N Engl J Med 1995; 333: 77-82.
8. STEVENSON WG, MIDDLEKAUFF H, STEVENSON LW, ET AL: Significance of aborted cardiac arrest and sustained ventricular tachycardia in patients referred for treatment therapy of advanced heart failure. Am Heart J 1992; 124: 123-130.
9. MIDDLEKAUFF H, STEVENSON WG, STEVENSON LW, SAXON L: Syncope in advanced heart failure: high risk of sudden death regardless of origin of syncope. J Am Coll Cardiol 1993; 21: 110-116.
10. MIDDLEKAUFF H, STEVENSON WG: Prognosis after syncope: impact of left ventricular function. Am Heart J 1993; 125: 121-126.
11. FRUHWALD F, EBER B, SCHUMACHER M, ET AL: Syncope in dilated cardiomyopathy is a predictor of sudden cardiac death. Cardiology 1996; 87: 177-180.
12. HAMILTON MA: Prevalence and clinical implications of abnormal thyroid hormone metabolism in advanced heart failure. Ann Thorac Surg 1993; 56: S48-S53.
13. OPASICH C, PACINI F, AMBROSINO N, ET AL: Sick Euthyroid Syndrome in patients with moderate-to-severe chronic heart failure. Eur Heart J 1996; 12, in press.
14. STEVENSON WG, STEVENSON LW, MIDDLEKAUFF H, ET AL: Improving survival for patients with advanced heart failure: a study of 737 consecutive patients. J Am Coll Cardiol 1995; 26: 1417-1423.
15. STEVENSON LW, PFEFFER MA: The philosophy of therapy for early heart failure: the need for surrogate endpoints. Heart Failure 1995; 6: 78-86.
16. LEVANTESI G, VOLPI A, DIMARCO G, ET AL: La funzione ventricolare sinistra nell'infarto del miocardio. Analisi delle variabili prognostiche nel database dello studio GIS-SI-2. G Ital Cardiol 1995; 25: 1177-1186.
17. SUTTON MS, PFEFFER MA, PLAPPERT T, ET AL: Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction. The protective effects of captopril. Circulation 1994; 89: 68-75.
18. BENEDICT C, FRANCIS G, SHELTON B, ET AL: Effect of long-term enalapril therapy on neurohormones in patients with left ventricular dysfunction. Am J Cardiol 1995; 75: 1151-1157.
19. KONSTAM M, KRONENBERG M, ROUSSEAU M, ET AL: Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dilatation in patients with asymptomatic systolic dysfunction. Circulation 1993; 88: 2277.
20. ROULEAU J, PACKER M, MOYÉ L, ET AL: Prognostic value of neurohumoral activation in patients with an acute myocardial infarction: effect of captopril. J Am Coll Cardiol 1994; 24: 583-591.
21. CARSON P, JOHNSON G, FLETCHER R, COHN J: Mild systolic dysfunction in heart failure (left ventricular ejection fraction >.35%): baseline characteristics, prognosis and response to therapy in the Vasodilator in Heart Failure Trials (V-HeFT). J Am Coll Cardiol 1996; 27: 642-649.
22. LA VECCHIA L, BEDOGNI F, BOZZOLA L, ET AL: Prediction of recovery after abstinence in alcoholic cardiomyopathy: role of hemodynamic and morphometric parameters. Clin Cardiol 1996; 19: 45-50.
23. PRAZAK P, PFISTERER M, OSSWALD S, ET AL: Differences of disease progression in congestive heart failure due to alcoholic as compared to idiopathic dilated cardiomyopathy. Eur Heart J 1996; 17: 251-257.
24. KERN MJ: Alcoholic cardiomyopathy: is outcome linked to stimulus withdrawal? Eur Heart J 1996; 17: 170-171.
25. LEVY D, LARSON M, VASAN R, ET AL: The progression from hypertension to congestive heart failure. JAMA 1996; 275: 1557-1562.
26. MOSER M, HEBERT P: Prevention of disease progression, left ventricular hypertrophy and congestive heart failure in hypertension treatment trials. J Am Coll Cardiol 1996; 27: 1214-1218.
27. SYTKOWSKI P, D'AGOSTINO R, BELANGER A, KANNEL W: Secular trends in long-term sustained hypertension, long-term treatment, and cardiovascular mortality. The Framingham Heart Study 1950 to 1990. Circulation 1996; 93: 697-703.
28. BAKER D, JONES R, MASSIE B, ET AL: Management of heart failure. III. Role of revascularization in the treatment of patients with moderate or severe left ventricular systolic dysfunction. JAMA 1994; 272: 1528-1534.
29. KOSTIS J, SHELTON B, GOSSELIN G, ET AL: Adverse effects of enalapril in the Studies of Left Ventricular Dysfunction (SOLVD). Am Heart J 1996; 131: 350-355
30. LUBSEN J, CHADHA D, YOTOF Y, SWEDBERG K: Meta-analysis of morbidity and mortality in five exercise capacity trails evaluating ramipril in chronic congestive cardiac failure. Am J Cardiol 1996; 77: 1191-1196.
31. STEWART D, LIANG C, KIRLIN P, ET AL: Effect of enalapril on exercise response of SOLVD patients with left ventricular dysfunction and mild symptoms. Heart Failure 1996; 1: 243-251.
32. SAKNER-BERNESTEIN D, MANCINI D: Rationale for treatment of patients with chronic heart failure with adrenergic blockade. JAMA 1995; 274: 1462-1467.
33. ZAREMBSKI D, NOLAN P, SLACK M, LUI C: Meta-analysis of the use of low-dose beta adrenergic blocking therapy in idiopathic or ischemic dilated cardiomyopathy. Am J Cardiol 1996; 77: 1247-1250.
34. THE VASODILATOR-HEART FAILURE TRIALS (V-HEFT). In: COHN J (ed): Supplement to Circulation. Circulation 1993; 87 (Suppl VI): 1-117.
35. WERNER G, SCHAEFER C, DIRKS R, ET AL: Prognostic value of Doppler echocardiographic assessment of left ventricular filling in idiopathic dilated cardiomyopathy. Am J Cardiol 1994, 73: 792-798.
36. MADSEN BK, HANSEN JF, STOKHOLM KH, ET AL: Chronic congestive heart failure. Description and survival of 190 consecutive patients with a diagnosis of chronic congestive heart failure based on clinical signs and symptoms. Eur Heart J 1994; 15: 303-310.
37. POZZOLI M, CAPOMOLLA S, PINNA G, ET AL: Doppler echocardiography reliably predicts pulmonary artery wedge pressure in patients with chronic heart failure with and without mitral regurgitation. J Am Coll Cardiol 1996; 27: 883-893.
38. KUBO S, OMAZA S, FRANCIS G, ET AL: Trends in patient selection for heart transplant. J Am Coll Cardiol 1993; 21: 975-981.
39. SAXON L, STEVENSON WG, MIDDLEKAUFF H, ET AL: Predicting death from progressive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 1993; 72: 62-65.
40. STEIMLE A, STEVENSON LW, FONAROW G, ET AL: Prediction of improvement in recent onset cardiomyopathy after referral for heart transplantation. J Am Coll Cardiol 1994; 23: 553-559.
41. STEVENSON L, STEIMLE A, CHELIMSKY-FALLICK C, ET AL: Outcomes predicted by peak oxygen consumption during evaluation of 333 patients with advanced heart failure. Circulation 1993; 88 (Suppl I): 94.
42. OPASICH C, FEBO O, RICCARDI G, ET AL: Concomitant factors of decompensation in chronic heart failure. Am J Cardiol 1996; 78: 354-357.
43. GHALI JK, KADAKIA S, COOPER R, FERLINZ J: Precipitating factors leading to decompensation of heart failure. Arch Intern Med 1988; 148: 2013-2016.
44. SHINDLER D, KOSTIS J, YUSUF S, ET AL: Diabetes mellitus, a predictor of morbidity and mortality in the Studies of Left Ventricular Dysfunction (SOLVD) Trials and Registry. Am J Cardiol 1996; 77: 1018-1020.
45. CARSON P, JOHNSON G, DUNKMAN B, ET AL: The influence of atrial fibrillation on prognosis in mild to moderate heart failure. Circulation 1993; 87 (Suppl VI): 102-110.
46. MIDDLEKAUFF HR, STEVENSON WG, STEVENSON LW: Prognostic significance of atrial fibrillation in advanced heart failure. Circulation 1991; 84: 40-48.
47. DUNKMAN WB, JOHNSON GR, CARSON PE, ET AL: Incidence of thromboembolic events in congestive heart failure. Circulation 1993; 87 (Suppl VI): 94-101.
48. PRYSTOWSKY E, BENSON W, FUSTER V, ET AL: Management of patients with atrial fibrillation. Circulation 1996; 93: 1262-1277.
49. DILENARDA A, GREGORI D, SINAGRA G, ET AL: Metoprolol in dilated cardiomyopathy: is it possible to identify factors predictive of improvement? Journal of Cardiac Failure 1996; 2: 87-102.
50. HUGHES CV, WONG M, JOHNSON G, ET AL: Influence of age on mechanisms and prognosis of heart failure. Circulation 1993; 87 (Suppl VI): 111-117.
51. HOLMES D, DETRE K, WILLIAMS D, ET AL: Long-term outcome of patients with depressed left ventricular function undergoing percutaneous transluminal coronary angioplasty. Circulation 1993; 87: 21-29.
52. ELEFTERIADES J, TOLIS G, LEVI E, ET AL: Coronary artery bypass grafting in severe left ventricular dysfunction: excellent survival with improved ejection fraction and functional state. J Am Coll Cardiol 1993; 22: 1141-1147.
53. SENIOR R, GLENVILLE B, BASU S, ET AL: Dobutamine echocardiography and thallium-201 imaging predict functional improvement after revascularization in severe ischaemic left ventricular dysfunction. Br Heart J 1995; 74: 358-364.
54. DI CARLI M, ASGARZADIE F, SCHELBERT H, ET AL: Quantitative relation between myocardial viability and improvement in heart failure symptoms after revascularization in patients with ischemic cardiomyopathy. Circulation 1995; 92: 3436-3444.
55. RISUM O, NITTER-HAUGE S, ABDELNOOR M, ET AL: Mortality and morbidity after coronary artery bypass surgery related to pre-operative left ventricular ejection fraction: a follow-up study. Eur Heart J 1996; 17: 874-879.
56. CALHOUN WB, MILLS R, DRANE W: Clinical importance of viability assessment in chronic ischemic heart failure. Clin Cardiol 1996; 19: 367-369.
57. CINTRON G, JOHNSON G, FRANCIS G, ET AL: Prognostic significance of serial changes in left ventricular ejection fraction in patients with congestive heart failure. Circulation 1993; 87 (Suppl VI): 17-23.
58. MANCINI D, EISEN H, KUSSMAUL W, ET AL: Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation 1991; 83: 778-786.
59. HAYWOOD GA, RICKENBACHER PR, TRINDADE PT, ET AL: Analysis of deaths in patients awaiting heart transplantation: impact on patient selection criteria. Heart 1996; 75: 455-462.
60. STEVENSON LW, COUPER G, NATTERSON B, ET AL: Target heart failure populations for newer therapies. Circulation 1995; 92 (Suppl II): 174-181.
61. CAMPANA C, GAVAZZI A, BERZUINI C, ET AL: Predictors of prognosis in patients awaiting heart transplantation. J Heart Lung Transpl 1993; 12: 756-765.
62. OZ M, ROSE E, LEVIN H: Selection criteria for placement of left ventricular assist devices. Am Heart J 1995; 129: 173-177.
63. BATIN P, WICKENS M, MCENTEGART D, ET AL: The importance of abnormalities of liver function tests in predicting mortality in chronic heart failure. Eur Heart J 1995; 16: 1613-1618.
64. FARRAR D, HILL H, AND THORATEC VENTRICULAR ASSIST DEVICE PRINCIPAL INVESTIGATORS: Recovery of major organ function in patients awaiting heart transplantation with Thoratec ventricular assist devices. J Heart Lung Transpl 1994; 13: 1125-1132.
65. LEE T, HAMILTON M, STEVENSON LW, ET AL: Impact of left ventricular cavity size on survival in advanced heart failure. Am J Cardiol 1993; 72: 672-676.
66. RICKENBACHER P, TRINDADE P, HAYWOOD G, ET AL: Transplant candidates with severe left ventricular dysfunction managed with medical treatment: characteristics and survival. J Am Coll Cardiol 1996; 27: 1192-1197.
67. OPASICH C, RICCARDI R, RICCARDI G, ET AL: Risultato del test cardiopolmonare: è realmente determinante nell'indicazione al trapianto cardiaco? In: ROVELLI F, DE VITA C, MOREO A (eds): Cardiologia 1994. Firenze, Scientific press, 1995; 693-698.
68. STEVENSON LW, COOPER G, NATTERSON B, ET AL: Target heart failure populations for newer therapies. Circulation 1995; 92 (Suppl II): 174-181.
69. RICH MW, BECKMAN V, WITTENBERG C, ET AL: A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. N Engl J Med 1995; 333: 1190-1195.
70. TAVAZZI L: Qualche considerazione sull'organizzazione dell'assistenza cardiologica. Il problema del cardiopatico cronico. G Ital Cardiol 1991; 21: 769-774.
71. EVIDENCE-BASED MEDICINE WORKING GROUP: Evidence-based medicine. A new approach to teaching the practice of medicine. JAMA 1992; 268: 2420-2425.
72. LAINE C, DAVIDOFF F: Patient-centered medicine. A professional evolution. JAMA 1996; 275: 152-156.